David Zaccardelli Verona Pharma PLC (VRNA) insider trading activity

David Zaccardelli is President and CEO of Verona Pharma plc. Currently has a direct ownership of 13.3 Million shares of VRNA, which is worth approximately $1.2 Billion. The most recent transaction as insider was on Jul 08, 2025, when has been sold 90,320 shares (Ordinary Shares) at a price of $11.44 per share, resulting in proceeds of $1,033,260. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.3M

6.38% 3M change

15.92% 12M change

Total Value Held $1.2 Billion

DAVID ZACCARDELLI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 08 2025	SELL Payment of exercise price or tax liability	$1,033,260 $11.44 p/Share	90,320 Reduced 0.67%	13,329,360 Ordinary Shares
Jul 07 2025	BUY Exercise of conversion of derivative security	-	229,512 Added 1.68%	13,419,680 Ordinary Shares
Jun 11 2025	SELL Open market or private sale	$4,560,000 $11.4 p/Share	400,000 Reduced 2.94%	13,190,168 Ordinary Shares
May 29 2025	SELL Open market or private sale	$1,947,133 $9.33 p/Share	208,696 Reduced 1.51%	13,590,168 Ordinary Shares
May 28 2025	SELL Open market or private sale	$1,466,647 $9.3 p/Share	157,704 Reduced 1.13%	13,798,864 Ordinary Shares
May 27 2025	SELL Open market or private sale	$320,208 $9.53 p/Share	33,600 Reduced 0.24%	13,956,568 Ordinary Shares
May 02 2025	SELL Open market or private sale	$3,636,000 $9.09 p/Share	400,000 Reduced 2.78%	13,990,168 Ordinary Shares
May 01 2025	SELL Open market or private sale	$1,673,721 $8.95 p/Share	187,008 Reduced 1.28%	14,390,168 Ordinary Shares
May 01 2025	BUY Exercise of conversion of derivative security	-	200,000 Added 1.36%	14,468,904 Ordinary Shares
Apr 29 2025	SELL Open market or private sale	$811,432 $8.98 p/Share	90,360 Reduced 0.62%	14,377,176 Ordinary Shares
Apr 29 2025	BUY Exercise of conversion of derivative security	-	229,512 Added 1.56%	14,467,536 Ordinary Shares
Feb 03 2025	SELL Payment of exercise price or tax liability	$1,193,772 $7.16 p/Share	166,728 Reduced 1.16%	14,238,024 Ordinary Shares
Feb 01 2025	BUY Grant, award, or other acquisition	-	200,000 Added 1.37%	14,404,752 Ordinary Shares
Dec 06 2024	SELL Open market or private sale	$815,628 $5.01 p/Share	162,800 Reduced 1.13%	14,204,752 Ordinary Shares
Dec 05 2024	SELL Open market or private sale	$3,207,722 $5.01 p/Share	640,264 Reduced 4.27%	14,367,552 Ordinary Shares
Dec 04 2024	SELL Open market or private sale	$338,040 $5.0 p/Share	67,608 Reduced 0.45%	15,007,816 Ordinary Shares
Dec 02 2024	SELL Open market or private sale	$16,000 $5.0 p/Share	3,200 Reduced 0.02%	15,075,424 Ordinary Shares
Nov 29 2024	SELL Open market or private sale	$495,428 $5.01 p/Share	98,888 Reduced 0.65%	15,078,624 Ordinary Shares
Nov 27 2024	SELL Open market or private sale	$116,200 $5.0 p/Share	23,240 Reduced 0.15%	15,177,512 Ordinary Shares
Nov 25 2024	SELL Open market or private sale	$8,000 $5.0 p/Share	1,600 Reduced 0.01%	15,200,752 Ordinary Shares
Nov 11 2024	SELL Open market or private sale	$12,000 $5.0 p/Share	2,400 Reduced 0.02%	15,202,352 Ordinary Shares
Nov 04 2024	SELL Open market or private sale	$413,292 $4.39 p/Share	94,144 Reduced 0.62%	15,204,752 Ordinary Shares
Nov 01 2024	SELL Open market or private sale	$205,369 $4.38 p/Share	46,888 Reduced 0.31%	15,298,896 Ordinary Shares
Nov 01 2024	SELL Payment of exercise price or tax liability	$1,042,836 $4.24 p/Share	245,952 Reduced 1.58%	15,345,784 Ordinary Shares
Nov 01 2024	BUY Grant, award, or other acquisition	-	200,000 Added 1.27%	15,591,736 Ordinary Shares

David Zaccardelli

President and CEO

London, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Verona Pharma plc

Track Activities on VRNA

Account